Professor Dr. Michael Hallek
Address
Uniklinik Köln
Klinik für Innere Medizin I
Kerpener Straße 62
50937 Köln
Projects
As Applicant
Completed projects
Charakterisierung von Src-Kinasen als molekulare Zielstruktur für die Therapie Philadelphia-positiver Leukämien.
(Research Grants)
Recombinant adeno-associated virus-mediated transgene delivery into porcine organs to allow immunological modifications of xenografts
(Research Units)
In vitro und in vivo Targeting von Melanomzellen mit Hilfe kapsidmodifizierter AAV2-Vektoren
(Research Grants)
Combinatorial selection of efficient and cell-type specific adeno-associated virus vectors (AAV) for human gene therapy
(Research Grants)
Function of tyrosine kinases Lyn and Btk in high-risk CLL
(Clinical Research Units)
Lyn kinase as a key regulator in the microenvironmental niche of B lymphoid tumors
(Research Grants)
As Spokesperson
Current projects
SFB 1530: Elucidation and targeting of pathogenic mechanisms in B cell malignancies
(Collaborative Research Centres)
Completed projects
SFB 832: Molecular Basis and Modulation of Cellular Interactions in the Tumour Microenvironment
(Collaborative Research Centres)
KFO 286: Exploiting Defects in the DNA Damage Response for the Treatment of Chronic Lymphocytic Leukemia
(Clinical Research Units)
As Participating Researcher
Completed projects
EXC 229: Cellular Stress Responses in Aging-Associated Diseases
(Clusters of Excellence)
As Project Head
Current projects
LYN kinase as a key regulator in the microenvironmental niche of B cell lymphoid tumors
(Collaborative Research Centres)
Central administration project
(Collaborative Research Centres)
Completed projects
Targeting von rekombinanten Adeno-assoziierten Virus-Vektoren
(Collaborative Research Centres)
Bestimmung der antigen-Spezifität der T-Zellantwort gegen eine genmodifizierte, polyvalente Vakzine bei der chronischen lymphatischen Leukämie (CLL)
(Collaborative Research Centres)
Molecular modulation of leukemia-associated macrophages in the microenvironment of chronic lymphocytic leukemia (CLL)
(Collaborative Research Centres)
Central administration
(Collaborative Research Centres)
Cell autonomous immune responses towards Adeno-associated virus (AAV) infection in the liver
(Collaborative Research Centres)
As Participating Person
Completed projects
Adenoassoziiertes Virus (AAV)-vermittelter Gentransfer zur Vermeidung von Venenbypass-Restenosen
(Research Grants)
Pathogenese der HIV-induzierten Blut-Hirn-Schrankenstörung und neuronalen Schädigung: Bedeutung des HIV-1-Regulatorproteins Nef
(Research Grants)
Zelleintritt und intrazelluläre Prozessierung von rAAV targeting Vektoren und ihrer Genome im lympho-hämatopoetischen System
(Priority Programmes)
As Co-Investigator
Completed projects
Long-read sequencing of SF3B1 mutated and wildtype chronic lymphocytic leukemia and myelodysplastic syndrome to identify mechanisms of genomic instability and therapy resistance and their impact on prognosis.
(Research Grants)